v3.25.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Stock-Based Compensation  
Schedule of stock option activity and related information

    

Number of Shares

    

Weighted - Average Exercise Price

    

Weighted-Average Remaining Contractual Term (in years)

    

Aggregate Intrinsic Value
(in thousands)

Outstanding - December 31, 2024

8,706,197

$

13.21

$

2,104

Granted

2,593,600

$

10.66

Exercised

(295,285)

$

6.17

$

1,112

Forfeited or cancelled

(389,043)

$

12.28

Outstanding - June 30, 2025

10,615,469

$

12.81

8.98

$

3,509

Options vested and exercisable as of June 30, 2025

1,633,000

$

8.95

7.55

$

2,063

Options vested and expected to vest as of June 30, 2025

10,615,469

$

12.81

8.98

$

3,509

Summary of company's RSU activity

    

Number of Shares

    

Weighted - Average Grant Date Fair Value

Unvested as of December 31, 2024

$

Granted

511,100

$

11.94

Vested

$

Forfeited

$

Unvested as of June 30, 2025

511,100

$

11.94

Schedule of stock-based compensation expense as reflected in consolidated statements of operations

The Company recognized stock-based compensation expense related to the issuance of equity awards to employees and directors in the condensed consolidated statement of operations as follows (in thousands):

Three Months Ended June 30,

Six Months Ended June 30,

2025

2024

2025

2024

Research and development

$

2,113

$

711

$

3,694

$

1,120

General and administrative

3,932

825

7,737

1,363

Total stock-based compensation expense

$

6,045

$

1,536

$

11,431

$

2,483